Showing results (241-250 of 269) with videos related to

Sort By:
Pageof 27
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 25, 2018
Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXTR A Bray, H M Gebel, R Townsend, et al.
Journal of Synchrotron Radiation|August 25, 2007
XAS and XMCD under high magnetic field and low temperature on the energy-dispersive beamline of the ESRFO Mathon, P van der Linden, T Neisius, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 29, 2011
The PROMISE study: a phase 2b multicenter study of voclosporin (ISA247) versus tacrolimus in de novo kidney transplantationS Busque, M Cantarovich, S Mulgaonkar, et al.
Kidney International|September 6, 2000
Effect of waiting time on renal transplant outcomeH U Meier-Kriesche, F K Port, A O Ojo, et al.
Transplantation|August 10, 2000
Relationship of recipient age and development of chronic allograft failureH U Meier-Kriesche, A O Ojo, D M Cibrik, et al.
Transplantation|March 10, 2001
Interaction of mycophenolate mofetil and HLA matching on renal allograft survivalH U Meier-Kriesche, A O Ojo, A B Leichtman, et al.
Transplantation|March 10, 2001
Gender differences in the risk for chronic renal allograft failureH U Meier-Kriesche, A O Ojo, S F Leavey, et al.
Carcinogenesis|October 9, 2012
Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2Peter H Killian, Emanuel Kronski, Katharina M Michalik, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 28, 2016
Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT-EXT at 7 Years After TransplantS Florman, T Becker, B Bresnahan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2009
Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trialR S Gaston, B Kaplan, T Shah, et al.
Pageof 27